Original peer-reviewed publications:
1. Jhamb M, Weltman MR, Yabes JG, Kamat S, Devaraj SM, Fischer GS, Rollman BL, Nolin TD, Abdel-Kader K. Electronic health record based population health management to optimize care in CKD: Design of the Kidney Coordinated HeAlth Management Partnership (K-CHAMP) trial. Contemp Clin Trials. 2023;131:107269. PMID: 37348600
2. Jhamb M, Weltman MR, Devaraj SM, Lavenburg LM, Han Z, Alghwiri AA, Fischer GS, Rollman BL, Nolin TD, Yabes JG. Electronic Health Record Population health management to optimize CKD care: Cluster Randomized Trial. JAMA Intern Med. 2024 Jul 1;184(7):737-747. PMID: 38619824; PMCID: PMC11019443.
3. Weltman, Melanie R.1,2; Lavenburg, Linda-Marie U.1; Han, Zhuoheng1; Alghwiri, Alaa A.1; Mosslemi, Mitra3; Rollman, Bruce L.4,5; Fischer, Gary S.4; Nolin, Thomas D.1,2; Yabes, Jonathan G.6; Jhamb, Manisha1. Population Health Management and Guideline-Concordant Care in CKD: A Secondary Analysis of Kidney Coordinated HeAlth Management Partnership. Journal of the American Society of Nephrology ():10.1681/ASN.0000000544, November 1, 2024.
Other Peer-reviewed publications (editorials):
1. Abdel-Kader K, Jhamb M. EHR-based Clinical Trials: The Next Generation of Evidence for CKD care. Clin J Am Soc Nephrol 2020 Jul 1;15(7):1050-1052. PMID: 32094245; PMCID: PMC7341790
2. Jhamb M. Innovations in Population Health: Improving Outcomes for Patients with Chronic Kidney Disease. Popul Health Manag. 2023 Aug;26(S1):S12-S13. PMID: 37603801; PMCID: PMC10460683.
Published Abstracts
1. Jhamb M, Weltman MR, Devaraj SM, Lavenburg LU, Han Z, Alghwiri AA, Fischer G, Rollman BL, Nolin TD, Yabes J. Electronic Health Record-Based Population Health Management to Optimize Care in CKD: Kidney CHAMP Randomized Clinical Trial. J Am Soc Nephrol 34, 2023: B15.
2. Weltman MR, Han Z, Alghwiri AA, Yabes J, Lavenburg LU, Nolin TD, Jhamb M. Use of guideline-recommended medication therapy in a high-risk chronic kidney disease population in the Kidney CHAMP trial. J Am Soc Nephrol 34, 2023: 804.
3. Lavenburg L, Devaraj S, Hamm M, Kenkre BN, Cameron F, Abdel-Kader K, Jhamb M. Primary care Provider Perceptions of a Population Health Management Program to Improve Kidney Care. Am J Kidney Dis 2023;81(4):S109.
4. Devaraj SM, Yabes J, Cai M, Lavenburg LU, Abdel-Kader K, Jhamb M. A Demographic and Community Characteristic Comparison of Advanced CKD Patients Seeing vs. Not Seeing a Nephrologist. J Am Soc Nephrol 33, 2022: 253.
5. Devaraj SM, Hamm ME, Kenkre BN, Cameron F, Abdel-Kader K, Jhamb M. Patient Perceptions of a CKD Population Health Management Program to Improve Kidney Care. J Am Soc Nephrol 33, 2022: 865.
6. Weltman MR, Jhamb M, Yabes JG, Cai M, Nolin TD, Abdel-Kader K. Acceptance of recommendations for SGLT2 inhibitors and GLP1 receptor agonists in a high-risk CKD population. J Am Soc Nephrol 33, 2022: 865.
7. Weltman MR, Cai M, Yabes JG, Abdel-Kader K, Jhamb M, Nolin TD. Identification of common medication therapy problems in a high-risk CKD population. J Am Soc Nephrol 32, 2021: 733.
8. Chen H, Jhamb M, Weltman MR, Nolin TD, Abdel-Kader K. Epidemiology of patients with high-risk chronic kidney disease: A demographic evaluation of patients who had indications for SGLT2 inhibitors. J Am Soc Nephrol 31, 2020: 226.
9. Weltman MR, Chen H, Yabes JG, Cai M, Abdel-Kader K, Jhamb M, Nolin TD. Uptake of evidence-based recommendations to improve care for chronic kidney disease patients in the Kidney Coordinated Health Management Partnership (Kidney CHAMP) Study. J Am Soc Nephrol 31, 2020: 207.
10. Chen H, Weltman MR, Yabes JG, Cai M, Nolin TD, Abdel-Kader K, Jhamb M. Epidemiology of Patients with Advanced Chronic Kidney Disease: A Demographic Comparison of Patients with and without Nephrology Visits. Am J Kidney Dis 2020;75(4):557.
11. Weltman MR, Chen H, Yabes JG, Cai M, Abdel-Kader K, Jhamb M, Nolin TD. Frequency of medication therapy problems in a high-risk chronic kidney disease population. Am J Kidney Dis 2020;75(4):653.
12. Jhamb M, Yabes J, Fischer G, Chang CH, Rollman BL, Nolin TD, Abdel-Kader K. Electronic Health Record Based Population Health Management for Improving CKD Care: The Kidney-Coordinated Health Management Partnership (CHAMP) Study. J Am Soc Nephrol 30, 2019: 525.
Oral presentation
Weltman M. Acceptance Of Recommendations for SGLT2 Inhibitors and GLP1 Receptor Agonists in a High-Risk Chronic Kidney Disease Population in The Kidney CHAMP Trial. University of Pittsburgh Department of Medicine 21st Annual Research Day, Apr 2023. Received Outstanding Plenary Presentation award